Cerebral nocardiosis in a patient treated with pembrolizumab: a first case report
Abstract Background Checkpoints inhibitors (CPIs) are increasingly used for the treatment of several malignancies. The most common side effects are Immune Related Adverse Events, while infectious complications are rare, especially cerebral nocardiosis. Case presentation Here, we report the first cli...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2022-03-01
|
| Colecção: | BMC Infectious Diseases |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s12879-022-07288-4 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|